Covered recipient · General Payments record
RUSTY M JONES
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2023
$440.01
- Reported across 19 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $198.04 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $62.85 | 3 |
| Corium, Inc. | $36.19 | 2 |
| Lilly USA, LLC | $18.64 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $17.96 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.77 | 1 |
| IRONSHORE PHARMACEUTICALS INC. | $16.84 | 1 |
| PFIZER INC. | $14.21 | 1 |
| Acerta Pharma LLC | $13.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $13.58 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014939679 | CMS |
| Boston Scientific Corporation | $17.96 | 12/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022577561 | CMS |
| Corium, LLC | $11.63 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 977964315 | CMS |
| Corium, LLC | $24.56 | 04/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978142425 | CMS |
| Ironshore Pharmaceuticals Inc. | $16.84 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060453315 | CMS |
| Lilly USA, LLC | $18.64 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1032172173 | CMS |
| Novartis Pharmaceuticals Corporation | $17.77 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 992064853 | CMS |
| Novo Nordisk Inc | $23.59 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003019377 | CMS |
| Novo Nordisk Inc | $20.11 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003019367 | CMS |
| Novo Nordisk Inc | $19.15 | 09/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003019355 | CMS |
| PFIZER INC. | $14.21 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050547667 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.